221 related articles for article (PubMed ID: 27468959)
1. Successful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case report.
Minami K; Sakaguchi Y; Yoshida D; Yamamoto M; Ikebe M; Morita M; Toh Y
Surg Case Rep; 2016 Dec; 2(1):76. PubMed ID: 27468959
[TBL] [Abstract][Full Text] [Related]
2. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
3. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
[TBL] [Abstract][Full Text] [Related]
4. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.
Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H
Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733
[TBL] [Abstract][Full Text] [Related]
5. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
6. The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study.
Akatsuka M; Masuda Y; Tatsumi H; Sonoda T
J Intensive Care; 2020 Dec; 8(1):94. PubMed ID: 33308326
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
[TBL] [Abstract][Full Text] [Related]
8. Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.
Hayakawa M
Open Access Emerg Med; 2018; 10():25-29. PubMed ID: 29343993
[TBL] [Abstract][Full Text] [Related]
9. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
[TBL] [Abstract][Full Text] [Related]
10. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry.
Cutuli SL; Artigas A; Fumagalli R; Monti G; Ranieri VM; Ronco C; Antonelli M;
Ann Intensive Care; 2016 Dec; 6(1):77. PubMed ID: 27502196
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin improves fulminant pseudomembranous colitis by reducing the elevated endogenous cannabinoids and inflammatory cytokines: report of a case.
Kimura Y; Sato K; Tokuda H; Hashiguchi T; Maruyama I; Orito E; Dohi Y; Joh T
Hepatogastroenterology; 2008; 55(84):956-8. PubMed ID: 18705306
[TBL] [Abstract][Full Text] [Related]
12. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
[TBL] [Abstract][Full Text] [Related]
13. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
14. Effects of combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin on fulminant pseudomembranous colitis with septic shock.
Kimura Y; Sato K; Tokuda H; Nakamura N; Dohi Y; Orito E; Mizokami M
Dig Dis Sci; 2007 Mar; 52(3):675-8. PubMed ID: 17273924
[TBL] [Abstract][Full Text] [Related]
15. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.
Kim JJ; Park YJ; Moon KY; Park JH; Jeong YK; Kim EY
World J Gastrointest Surg; 2019 Dec; 11(12):422-432. PubMed ID: 31879534
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study).
Ogura T; Eguchi T; Nakahara K; Kanno Y; Omoto S; Itonaga M; Kuroda T; Hakoda A; Ikeoka S; Takagi M; Okada A; Sato J; Morita R; Michikawa Y; Ito K; Koshita S; Takenaka M; Kitano M; Koizumi M; Higuchi K
J Hepatobiliary Pancreat Sci; 2023 Feb; 30(2):221-228. PubMed ID: 34021720
[TBL] [Abstract][Full Text] [Related]
18. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
[TBL] [Abstract][Full Text] [Related]
20. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
